In a move that health experts say may reduce the number of fentanyl deaths, the FDA has approved over-the-counter sales of ...
The FDA has approved Amneal Pharmaceuticals’ ( NASDAQ: AMRX) OTC Naloxone HCl nasal spray, a generic version of the opioid ...
Incannex Healthcare Inc. (NASDAQ:IXHL), a cannabinoid and psychedelic medicine biotechnology company, announced the successful completion of a pre-investigational new drug meeting with the U.S. Food ...
California is partnering with a New Jersey-based pharmaceutical company to purchase a generic version of Narcan, the most ...
Providing access to naloxone and appropriate training can protect workers and possibly save someone's life, says ISEA.
MELBOURNE, Australia and NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), (Incannex or the Company), a leading cannabinoid and psychedelic medicine biotechnology ...
After its approval, the first OTC product didn't actually hit store shelves until September 2023. This followed decades of ...
Repurposing a Food and Drug Administration (FDA)-approved drug for a new use has been informally practiced for years. In fact ...
The nasal spray product delivers 10mg of naloxone hydrochloride in a single dose. The Food and Drug Administration (FDA) has approved Rezenopy (naloxone hydrochloride) nasal spray for the emergency ...
Amneal Pharmaceuticals, Inc. (AMRX) announced on Wednesday that it has received FDA approval for its Over the Counter Naloxone ...
In Pennsylvania, accidental drug overdoses are now the number one cause of death for people under 40, killing more than 5,000 in our state every year. Most of the drug overdoses are caused by ...
Incannex Healthcare Inc. (Nasdaq: IXHL), (Incannex or the Company), a leading cannabinoid and psychedelic medicine biotechnology company ...